Annual CAPEX
$66.30 M
-$43.90 M-39.84%
31 March 2024
Summary:
Haemonetics annual capital expenditures is currently $66.30 million, with the most recent change of -$43.90 million (-39.84%) on 31 March 2024. During the last 3 years, it has risen by +$29.26 million (+78.98%). HAE annual CAPEX is now -45.76% below its all-time high of $122.22 million, reached on 28 March 2015.HAE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$9.43 M
+$3.78 M+66.78%
28 September 2024
Summary:
Haemonetics quarterly capital expenditures is currently $9.43 million, with the most recent change of +$3.78 million (+66.78%) on 28 September 2024. Over the past year, it has increased by +$320.00 thousand (+3.51%). HAE quarterly CAPEX is now -80.55% below its all-time high of $48.49 million, reached on 29 September 2018.HAE Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$64.59 M
+$320.00 K+0.50%
28 September 2024
Summary:
Haemonetics TTM capital expenditures is currently $64.59 million, with the most recent change of +$320.00 thousand (+0.50%) on 28 September 2024. Over the past year, it has increased by +$19.03 million (+41.77%). HAE TTM CAPEX is now -54.90% below its all-time high of $143.20 million, reached on 01 September 2022.HAE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HAE CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -39.8% | +3.5% | +41.8% |
| 3 y3 years | +79.0% | -64.6% | -11.6% |
| 5 y5 years | -44.3% | -0.4% | +6.4% |
HAE CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -39.8% | +79.0% | -79.3% | +66.8% | -54.9% | +41.8% |
| 5 y | 5 years | -44.3% | +79.0% | -79.3% | +66.8% | -54.9% | +79.2% |
| alltime | all time | -45.8% | +481.5% | -80.5% | +288.7% | -54.9% | +1475.4% |
Haemonetics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $9.43 M(+66.8%) | $64.59 M(+0.5%) |
| June 2024 | - | $5.66 M(-41.6%) | $64.27 M(-3.1%) |
| Mar 2024 | $66.30 M(-39.8%) | - | - |
| Mar 2024 | - | $9.69 M(-75.7%) | $66.30 M(-3.3%) |
| Dec 2023 | - | $39.82 M(+336.9%) | $68.53 M(+50.4%) |
| Sept 2023 | - | $9.11 M(+18.6%) | $45.56 M(-37.1%) |
| June 2023 | - | $7.68 M(-35.6%) | $72.41 M(-34.3%) |
| Mar 2023 | $110.19 M(+14.2%) | $11.92 M(-29.3%) | $110.19 M(-17.4%) |
| Dec 2022 | - | $16.85 M(-53.1%) | $133.39 M(-6.9%) |
| Sept 2022 | - | $35.96 M(-20.9%) | $143.20 M(+11.8%) |
| June 2022 | - | $45.47 M(+29.5%) | $128.06 M(+32.7%) |
| Mar 2022 | $96.51 M(+160.6%) | $35.12 M(+31.7%) | $96.51 M(+32.2%) |
| Dec 2021 | - | $26.66 M(+28.1%) | $73.03 M(+31.0%) |
| Sept 2021 | - | $20.81 M(+49.5%) | $55.74 M(+28.8%) |
| June 2021 | - | $13.92 M(+19.7%) | $43.26 M(+16.8%) |
| Mar 2021 | $37.04 M(-24.0%) | $11.63 M(+24.1%) | $37.04 M(+2.7%) |
| Dec 2020 | - | $9.37 M(+12.4%) | $36.05 M(-23.4%) |
| Sept 2020 | - | $8.34 M(+8.4%) | $47.07 M(-2.4%) |
| June 2020 | - | $7.70 M(-27.7%) | $48.20 M(-1.1%) |
| Mar 2020 | $48.76 M(-59.0%) | $10.65 M(-47.8%) | $48.76 M(-5.9%) |
| Dec 2019 | - | $20.39 M(+115.2%) | $51.83 M(-14.6%) |
| Sept 2019 | - | $9.47 M(+14.8%) | $60.68 M(-39.1%) |
| June 2019 | - | $8.25 M(-39.9%) | $99.70 M(-16.2%) |
| Mar 2019 | $118.96 M(+59.0%) | $13.72 M(-53.1%) | $118.96 M(-4.3%) |
| Dec 2018 | - | $29.24 M(-39.7%) | $124.35 M(+2.2%) |
| Sept 2018 | - | $48.49 M(+76.2%) | $121.68 M(+37.3%) |
| June 2018 | - | $27.51 M(+44.0%) | $88.59 M(+18.4%) |
| Mar 2018 | $74.80 M(-1.8%) | $19.10 M(-28.1%) | $74.80 M(+4.9%) |
| Dec 2017 | - | $26.57 M(+72.5%) | $71.31 M(+12.1%) |
| Sept 2017 | - | $15.40 M(+12.3%) | $63.64 M(-5.6%) |
| June 2017 | - | $13.72 M(-12.1%) | $67.38 M(-11.5%) |
| Mar 2017 | $76.14 M(-25.7%) | $15.62 M(-17.3%) | $76.14 M(-14.5%) |
| Dec 2016 | - | $18.89 M(-1.3%) | $89.05 M(-5.2%) |
| Sept 2016 | - | $19.14 M(-14.8%) | $93.90 M(-6.7%) |
| June 2016 | - | $22.48 M(-21.2%) | $100.64 M(-1.7%) |
| Mar 2016 | $102.41 M(-16.2%) | $28.53 M(+20.2%) | $102.41 M(+7.2%) |
| Dec 2015 | - | $23.74 M(-8.3%) | $95.56 M(-5.8%) |
| Sept 2015 | - | $25.88 M(+6.8%) | $101.48 M(-7.2%) |
| June 2015 | - | $24.25 M(+11.8%) | $109.38 M(-10.5%) |
| Mar 2015 | $122.22 M(+66.0%) | $21.69 M(-26.9%) | $122.22 M(-6.3%) |
| Dec 2014 | - | $29.66 M(-12.2%) | $130.46 M(+12.2%) |
| Sept 2014 | - | $33.79 M(-8.9%) | $116.32 M(+19.1%) |
| June 2014 | - | $37.09 M(+23.9%) | $97.64 M(+32.6%) |
| Mar 2014 | $73.65 M(+18.4%) | $29.93 M(+92.8%) | $73.65 M(+31.0%) |
| Dec 2013 | - | $15.52 M(+2.7%) | $56.22 M(+0.5%) |
| Sept 2013 | - | $15.11 M(+15.4%) | $55.96 M(-16.3%) |
| June 2013 | - | $13.09 M(+4.7%) | $66.84 M(+7.5%) |
| Mar 2013 | $62.19 M(+16.9%) | $12.50 M(-18.0%) | $62.19 M(-5.7%) |
| Dec 2012 | - | $15.25 M(-41.3%) | $65.92 M(+3.4%) |
| Sept 2012 | - | $25.99 M(+207.9%) | $63.79 M(+28.0%) |
| June 2012 | - | $8.44 M(-48.0%) | $49.84 M(-6.3%) |
| Mar 2012 | $53.20 M(+14.0%) | $16.24 M(+23.8%) | $53.20 M(+9.4%) |
| Dec 2011 | - | $13.12 M(+8.9%) | $48.64 M(+4.8%) |
| Sept 2011 | - | $12.04 M(+2.0%) | $46.42 M(+7.3%) |
| June 2011 | - | $11.80 M(+1.0%) | $43.25 M(-7.3%) |
| Mar 2011 | $46.67 M(-17.1%) | $11.68 M(+7.2%) | $46.67 M(+0.5%) |
| Dec 2010 | - | $10.90 M(+22.9%) | $46.41 M(-2.3%) |
| Sept 2010 | - | $8.86 M(-41.8%) | $47.51 M(-5.6%) |
| June 2010 | - | $15.22 M(+33.2%) | $50.32 M(-10.6%) |
| Mar 2010 | $56.30 M(-0.1%) | $11.43 M(-4.7%) | $56.30 M(+1.3%) |
| Dec 2009 | - | $12.00 M(+2.7%) | $55.59 M(-8.1%) |
| Sept 2009 | - | $11.68 M(-44.9%) | $60.48 M(-7.2%) |
| June 2009 | - | $21.20 M(+98.0%) | $65.19 M(+15.6%) |
| Mar 2009 | $56.38 M(-2.4%) | $10.71 M(-36.6%) | $56.38 M(-7.5%) |
| Dec 2008 | - | $16.89 M(+3.1%) | $60.96 M(+2.8%) |
| Sept 2008 | - | $16.38 M(+32.2%) | $59.31 M(+1.0%) |
| June 2008 | - | $12.39 M(-18.9%) | $58.74 M(+1.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | $57.79 M(+39.4%) | $15.29 M(+0.3%) | $57.79 M(+1.4%) |
| Dec 2007 | - | $15.24 M(-3.6%) | $56.97 M(+10.8%) |
| Sept 2007 | - | $15.81 M(+38.1%) | $51.42 M(+20.7%) |
| June 2007 | - | $11.45 M(-20.9%) | $42.60 M(+2.8%) |
| Mar 2007 | $41.46 M(+12.7%) | $14.47 M(+49.3%) | $41.46 M(+8.0%) |
| Dec 2006 | - | $9.70 M(+38.8%) | $38.38 M(-11.8%) |
| Sept 2006 | - | $6.98 M(-32.2%) | $43.53 M(+7.2%) |
| June 2006 | - | $10.31 M(-9.5%) | $40.60 M(+10.4%) |
| Mar 2006 | $36.77 M(+109.8%) | $11.39 M(-23.3%) | $36.77 M(+22.9%) |
| Dec 2005 | - | $14.85 M(+266.2%) | $29.93 M(+43.3%) |
| Sept 2005 | - | $4.05 M(-37.4%) | $20.88 M(+3.1%) |
| June 2005 | - | $6.48 M(+42.3%) | $20.25 M(+15.5%) |
| Mar 2005 | $17.53 M(+26.5%) | $4.55 M(-21.6%) | $17.53 M(-9.2%) |
| Dec 2004 | - | $5.80 M(+69.7%) | $19.31 M(+35.7%) |
| Sept 2004 | - | $3.42 M(-9.0%) | $14.23 M(-2.0%) |
| June 2004 | - | $3.76 M(-40.6%) | $14.52 M(+4.8%) |
| Mar 2004 | $13.86 M(-17.1%) | $6.33 M(+771.5%) | $13.86 M(-8.3%) |
| Dec 2003 | - | $726.00 K(-80.4%) | $15.12 M(-25.7%) |
| Sept 2003 | - | $3.71 M(+19.7%) | $20.35 M(+19.4%) |
| June 2003 | - | $3.10 M(-59.2%) | $17.05 M(+2.0%) |
| Mar 2003 | $16.71 M(-26.3%) | $7.59 M(+27.4%) | $16.71 M(+2.6%) |
| Dec 2002 | - | $5.96 M(+1352.7%) | $16.29 M(+8.8%) |
| Sept 2002 | - | $410.00 K(-85.2%) | $14.97 M(-33.5%) |
| June 2002 | - | $2.76 M(-61.4%) | $22.51 M(-0.7%) |
| Mar 2002 | $22.68 M(+40.4%) | $7.16 M(+54.3%) | $22.68 M(+2.9%) |
| Dec 2001 | - | $4.64 M(-41.6%) | $22.04 M(+5.7%) |
| Sept 2001 | - | $7.95 M(+171.7%) | $20.86 M(+31.4%) |
| June 2001 | - | $2.93 M(-55.2%) | $15.88 M(-1.7%) |
| Mar 2001 | $16.15 M(-30.7%) | $6.53 M(+88.8%) | $16.15 M(+37.6%) |
| Dec 2000 | - | $3.46 M(+16.5%) | $11.73 M(-6.7%) |
| Sept 2000 | - | $2.97 M(-7.1%) | $12.58 M(-35.9%) |
| June 2000 | - | $3.19 M(+51.1%) | $19.61 M(-15.9%) |
| Mar 2000 | $23.32 M(+3.8%) | $2.12 M(-50.8%) | $23.32 M(-11.6%) |
| Dec 1999 | - | $4.30 M(-57.0%) | $26.37 M(-16.7%) |
| Sept 1999 | - | $10.00 M(+44.9%) | $31.67 M(+23.9%) |
| June 1999 | - | $6.90 M(+33.6%) | $25.57 M(+13.8%) |
| Mar 1999 | $22.47 M(+10.1%) | $5.17 M(-46.2%) | $22.47 M(+82.7%) |
| Dec 1998 | - | $9.60 M(+146.2%) | $12.30 M(-12.8%) |
| Sept 1998 | - | $3.90 M(+2.6%) | $14.10 M(-15.6%) |
| June 1998 | - | $3.80 M(-176.0%) | $16.70 M(-18.1%) |
| Mar 1998 | $20.40 M(-44.4%) | -$5.00 M(-143.9%) | $20.40 M(-42.4%) |
| Dec 1997 | - | $11.40 M(+75.4%) | $35.40 M(+1.7%) |
| Sept 1997 | - | $6.50 M(-13.3%) | $34.80 M(-13.0%) |
| June 1997 | - | $7.50 M(-25.0%) | $40.00 M(+9.0%) |
| Mar 1997 | $36.70 M(+86.3%) | $10.00 M(-7.4%) | $36.70 M(+34.4%) |
| Dec 1996 | - | $10.80 M(-7.7%) | $27.30 M(+2.2%) |
| Sept 1996 | - | $11.70 M(+178.6%) | $26.70 M(+36.9%) |
| June 1996 | - | $4.20 M(+600.0%) | $19.50 M(-1.0%) |
| Mar 1996 | $19.70 M(-20.9%) | $600.00 K(-94.1%) | $19.70 M(-17.2%) |
| Dec 1995 | - | $10.20 M(+126.7%) | $23.80 M(+21.4%) |
| Sept 1995 | - | $4.50 M(+2.3%) | $19.60 M(-14.4%) |
| June 1995 | - | $4.40 M(-6.4%) | $22.90 M(-8.0%) |
| Mar 1995 | $24.90 M(+8.7%) | $4.70 M(-21.7%) | $24.90 M(-3.9%) |
| Dec 1994 | - | $6.00 M(-23.1%) | $25.90 M(+7.0%) |
| Sept 1994 | - | $7.80 M(+21.9%) | $24.20 M(+13.6%) |
| June 1994 | - | $6.40 M(+12.3%) | $21.30 M(-7.0%) |
| Mar 1994 | $22.90 M(+30.1%) | $5.70 M(+32.6%) | $22.90 M(0.0%) |
| Dec 1993 | - | $4.30 M(-12.2%) | $22.90 M(-3.8%) |
| Sept 1993 | - | $4.90 M(-38.8%) | $23.80 M(+8.7%) |
| June 1993 | - | $8.00 M(+40.4%) | $21.90 M(+24.4%) |
| Mar 1993 | $17.60 M(+54.4%) | $5.70 M(+9.6%) | $17.60 M(+22.2%) |
| Dec 1992 | - | $5.20 M(+73.3%) | $14.40 M(+34.6%) |
| Sept 1992 | - | $3.00 M(-18.9%) | $10.70 M(-2.7%) |
| June 1992 | - | $3.70 M(+48.0%) | $11.00 M(-3.5%) |
| Mar 1992 | $11.40 M | $2.50 M(+66.7%) | $11.40 M(+28.1%) |
| Dec 1991 | - | $1.50 M(-54.5%) | $8.90 M(+20.3%) |
| Sept 1991 | - | $3.30 M(-19.5%) | $7.40 M(+80.5%) |
| June 1991 | - | $4.10 M | $4.10 M |
FAQ
- What is Haemonetics annual capital expenditures?
- What is the all time high annual CAPEX for Haemonetics?
- What is Haemonetics annual CAPEX year-on-year change?
- What is Haemonetics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Haemonetics?
- What is Haemonetics quarterly CAPEX year-on-year change?
- What is Haemonetics TTM capital expenditures?
- What is the all time high TTM CAPEX for Haemonetics?
- What is Haemonetics TTM CAPEX year-on-year change?
What is Haemonetics annual capital expenditures?
The current annual CAPEX of HAE is $66.30 M
What is the all time high annual CAPEX for Haemonetics?
Haemonetics all-time high annual capital expenditures is $122.22 M
What is Haemonetics annual CAPEX year-on-year change?
Over the past year, HAE annual capital expenditures has changed by -$43.90 M (-39.84%)
What is Haemonetics quarterly capital expenditures?
The current quarterly CAPEX of HAE is $9.43 M
What is the all time high quarterly CAPEX for Haemonetics?
Haemonetics all-time high quarterly capital expenditures is $48.49 M
What is Haemonetics quarterly CAPEX year-on-year change?
Over the past year, HAE quarterly capital expenditures has changed by +$320.00 K (+3.51%)
What is Haemonetics TTM capital expenditures?
The current TTM CAPEX of HAE is $64.59 M
What is the all time high TTM CAPEX for Haemonetics?
Haemonetics all-time high TTM capital expenditures is $143.20 M
What is Haemonetics TTM CAPEX year-on-year change?
Over the past year, HAE TTM capital expenditures has changed by +$19.03 M (+41.77%)